South Korea’s entry into Horizon Europe has granted Korean startups access to major European research funding, but many struggle with positioning. The core issue isn’t access but alignment: Korea’s startup ecosystem prioritizes commercialization and market entry through programs like TIPS, while Horizon Europe evaluates projects based on Technology Readiness Levels and research contribution at earlier innovation stages. Erel Rosenberg of i46 notes European startups often target industry-focused programs like Eurostars and Eureka instead. Korea joined Eureka in 2005, with over 1,900 organizations participating in 248 projects, generating EUR 100 million commercially. Success requires choosing funding programs matching a startup’s development stage, not just applying broadly.
In-Depth:
South Korea’s entest into Horizon Europe has opened access to one of the largest public research and innovation funding systems in the world. Korean startups can now participate under largely equivalent conditions alongside European partners.
Yet across the ecosystem, a quieter pattern is emerging. Even when capable teams engage with the system, many struggle to position themselves effectively.
Now, the issue is apparently no longer in access. Becautilize access has now been wide open. Instead, it lies in the alignment: most especially in how Korean startups define progress, and how Horizon Europe evaluates it.
Korea’s Startup Model Is Built Around Commercialization Momentum
Korea’s startup support system is designed to accelerate commercialization. Programs such as TIPS connect private investment with R&D funding, mentoring, and global market expansion.
Public data reflects this structure. Under Korea’s startup policy framework, programs linked to TIPS include commercialization and overseas marketing support of up to KRW 200 million over ten months, post-TIPS scaling support reaching KRW 500 million over eighteen months, and global expansion programs extconcludeing up to three years with funding ceilings around KRW 600 million.
These mechanisms reinforce a clear operational logic. Startups are encouraged to shift from technology development toward market entest, then scale through international expansion.
This approach has produced results. Korean startups are widely recognized for their execution speed, productization, and ability to enter global markets.
But that same strength does not always translate directly into Horizon Europe.
Horizon Europe Evaluates Innovation Differently
Horizon Europe is not structured as a commercialization funding program. It operates as the European Union’s flagship research and innovation framework, designed to support technological development aligned with policy priorities, scientific advancement, and long-term impact.
Funding opportunities are defined through work programs that organize projects around research objectives, innovation pathways, and strategic themes. So participation requires alignment not only with technical goals, but also with how those goals contribute to broader research and policy agconcludeas.
This modifys how projects are evaluated. A product with strong market potential may not automatically meet the expectations of a Horizon Europe call if it does not clearly fit the required innovation stage or research contribution.
The distinction becomes more visible through one specific framework: Technology Readiness Levels.
Technology Readiness Level Defines the Real Entest Point
Technology Readiness Level, commonly referred to as TRL, is utilized within European research funding to describe the maturity of a technology and its proximity to market deployment.
Guidance utilized across Horizon Europe explains that Research and Innovation Actions typically launch at lower TRLs, often in early-stage validation or experimental development phases. These projects are not always designed to support immediate commercialization. Instead, they aim to advance knowledge, validate concepts, or demonstrate feasibility under controlled conditions.
This then creates a practical mismatch.
Many Korean startups approach funding with a product already positioned for market entest or near-commercial deployment. Horizon Europe, in contrast, may expect a project to contribute to earlier-stage innovation, structured experimentation, or collaborative research outcomes.
The result is not rejection due to weak ideas. It is rejection due to misalignment in how the project is framed.
European Operators Often Do Not Start with Horizon Europe
This distinction is not only observed from outside Europe.
Erel Rosenberg, Co-CEO of i46, who has worked on European funding programs and collaborations with Korean partners, noted that even within Europe, startups do not always treat Horizon Europe as the primary entest point.
“Horizon Europe is focutilized on innovation, basic research, and a lower level of TRL,”
as discussion on Horizon Europe barrier continues, he explained in correspondence with KoreaTechDesk.
Rosenberg pointed to an alternative pathway.
“Other European programmes, such as Eureka, which have several sub-programs, are more focutilized on industrial research.”
And so, this difference influences behavior inside the European ecosystem itself.
“Startups from Europe normally tarreceive Eureka programs and not Horizon Europe.”
This indicates that the challenge is not limited to Korean startups, but stems from a broader distinction between how different European funding instruments are designed and applied.
Not All EU Funding Programs Serve the Same Purpose
Horizon Europe is only one part of the European research and innovation landscape.
Eureka, for example, operates as an intergovernmental network focutilized on technology- and business-driven research collaboration. Its cluster programs, including CELTIC-NEXT, are designed as industest-driven platforms connecting companies, research institutions, and universities to develop applied technologies.
Eurostars, another Eureka-linked instrument, is specifically built for innovative SMEs leading international R&D and innovation projects. It supports collaborative projects that are closer to market application compared to many Horizon Europe calls.
This distinction matters becautilize it determines whether a startup is applying to the right system for its stage of development.
While Horizon Europe often emphasizes research progression and policy-aligned innovation, programs such as Eurostars and CELTIC are structured around industrial relevance, SME participation, and market-oriented outcomes.
In fact, South Korea is not new within this landscape. Its engagement with Eureka dates back to 2005, with full membership achieved in 2022.
According to Eureka, more than 1,900 Korean organizations have participated in 248 projects, generating EUR 100 million in commercial outcomes and contributing to over 800 patents. This long-term involvement reflects a consistent strategy: applying industest-driven R&D collaboration as a bridge into global markets.
This assists explain why, in practice, many Korean companies find a more natural fit in programs built around industrial collaboration rather than research-first frameworks.
Rosenberg highlighted this as a practical entest point.
“The Eurostars program is an excellent starting point.”
After all, it is crucial to note that a startup’s choice of program is not just about funding availability. It is about selecting the system that matches their stage of development and business objective.
The Misalignment Is Structural, Not Capability-Based
Now, Korean startups are not underprepared for European collaboration. In many cases, they are highly capable in product development, engineering, and global expansion.
But the challenge is in the structural mismatch.
Korea’s startup ecosystem trains companies to optimize for commercialization, scaling, and market validation. Horizon Europe, however, often evaluates projects through research contribution, innovation maturity, and alignment with predefined program objectives.
That is why it turns into a significant translation gap.
A startup presenting a near-market product may emphasize traction, scalability, and revenue potential. But a Horizon Europe evaluator may instead view for experimental design, collaborative research value, and contribution to technological advancement at a specific TRL stage.
Both perspectives are valid. But they are not exactly aligned.
Choosing the Right Entest Path Matters More Than Applying Early
The implication for Korean startups is not to avoid Horizon Europe. It is to approach it with a clearer understanding of where it fits within a broader European funding strategy.
For early-stage research collaboration or technologies still evolving through validation, Horizon Europe may provide a suitable platform.
But for startups focutilized on industrial application, product development, and near-market innovation, programs such as Eurostars or Eureka clusters may offer a more aligned entest point.
The real question is not how difficult the program is, but whether it aligns with the startup’s stage of development and business direction.
And understanding this distinction can significantly modify how startups approach Europe. Instead of treating all EU funding as a single category, they can position themselves within the program that best matches their technology maturity and strategic goals.
From Misalignment to Strategic Positioning
South Korea’s integration into Horizon Europe marks a new phase in cross-border R&D participation. The system is open, and participation is increasing.
But the next challenge is not merely access. It is precision.
Startups entering European funding necessary to consider beyond eligibility and focus on where their technology and business model actually fit.
Horizon Europe is built to advance innovation through defined stages, while Korea’s startup ecosystem is structured to accelerate commercialization and market entest.
Both systems are effective, but they operate on different assumptions about what progress views like. And for Korean startups, the difference matters a lot.
That is why success in Europe is less about relocating quickly into Horizon Europe, and more about selecting the best funding pathway that aligns with their stage, objectives, and long-term strategy.
Key Takeaways
- Horizon Europe prioritizes research and innovation progression, often at lower Technology Readiness Levels (TRLs), not immediate commercialization.
- Korean startup programs emphasize commercialization and global expansion, creating a structural mismatch in funding expectations.
- Technology Readiness Level (TRL) is a critical framework in EU funding that defines what stage of innovation a project must represent.
- European startups themselves often launch with programs like Eurostars or Eureka, which are more aligned with industrial and market-driven R&D.
- Eureka clusters and Eurostars focus on SME-led, industest-driven collaboration, creating them practical entest points for startups.
- The main barrier is not capability, but misalignment between startup positioning and funding logic.
- Successful entest into EU funding requires choosing the right program, not just applying to Horizon Europe.
🤝 Looking to connect with verified Korean companies building globally?
Explore curated company profiles and request direct introductions through beSUCCESS Connect.
– Stay Ahead in Korea’s Startup Scene –
Get real-time insights, funding updates, and policy shifts shaping Korea’s innovation ecosystem.
➡️ Follow KoreaTechDesk on LinkedIn, X (Twitter), Threads, Bluesky, Telegram, Facebook, and WhatsApp Channel.
